Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease

被引:0
作者
Aller, R.
de Luis, D. A. [1 ]
Izaola, O.
de la Fuente, B.
Bachiller, R.
机构
[1] Univ Valladolid, Hosp Clin Univ, Sch Med, Inst Endocrinol & Nutr, Valladolid, Spain
关键词
Insulin resistance; High monunsaturated fat hypocaloric diet; High polyunsaturated fat hypocaloric diet; Nonalcoholic fatty liver disease; Obesity; INSULIN-RESISTANCE; LIFE-STYLE; STEATOHEPATITIS; OBESE; ASSOCIATION; TRANSAMINASES; ORLISTAT; WEIGHT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: Hyperaminotransferase is an important problem in obese patients. We decide to examine the changes in hyperaminotransferasemia after weight reduction in obese patients with and without NAFLD secondary to a high monounsaturated fat vs. a high polyunsaturated fat hypocaloric diets. PATIENTS AND METHODS: A population of 306 obese patients was randomly allocated to two groups: Diet M (high monounsaturated fat hypocaloric diet) and Diet P (high polyunsaturated fat hypocaloric diet). Patients were classified as group I (obese subjects; n=262) when serum ALT activity was normal or group II (NAFLD patients; n=44) when serum ALT activity was (>= 43 UI/L). RESULTS: In NAFLD group with diet M, BMI, weight, fat mass, waist circumference, systolic blood pressure, total cholesterol, LDL cholesterol), insulin and HOMA-R decreased. In NAFLD group with diet P, BMI, weight, fat mass, waist circumference, systolic blood pressure, total cholesterol, LDL cholesterol), insulin and HOMA-R decreased, too. In NAFLD group, alanine aminotransferase [(diet M) -20.3 +/- 19.2 UI/L vs. (diet P) 14.2 +/- 20.1 UI/L], aspartate aminotransferase [(diet M) -11.3 +/- 12.2 UI/L vs. (diet P) -11.1 +/- 10.1 UI/L], and gammaglutamyl transferase [(diet M) 18.1 +/- 12.2 UI/L vs. (diet P) -10.9 +/- 20.1 UI/L] improved with both diets. CONCLUSIONS: We showed that weight reduction secondary to two hypocaloric diets was associated with improvement in hypertransaminasemia and insulin resistance in NAFLD patients.
引用
收藏
页码:1041 / 1047
页数:7
相关论文
共 30 条
[1]   HEPATIC-EFFECTS OF DIETARY WEIGHT-LOSS IN MORBIDLY OBESE SUBJECTS [J].
ANDERSEN, T ;
GLUUD, C ;
FRANZMANN, MB ;
CHRISTOFFERSEN, P .
JOURNAL OF HEPATOLOGY, 1991, 12 (02) :224-229
[2]  
[Anonymous], BIOCH BIOPHYS ACTA
[3]   Obesity, diabetes mellitus, and liver fibrosis [J].
Chiang, Dian J. ;
Pritchard, Michele T. ;
Nagy, Laura E. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2011, 300 (05) :G697-G702
[4]   NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome [J].
Chitturi, S ;
Abeygunasekera, S ;
Farrell, GC ;
Holmes-Walker, J ;
Hui, JM ;
Fung, C ;
Karim, R ;
Lin, R ;
Samarasinghe, D ;
Liddle, C ;
Weltman, M ;
George, J .
HEPATOLOGY, 2002, 35 (02) :373-379
[5]  
Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5
[6]   Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance [J].
de Luis, D. A. ;
Aller, R. ;
Izaola, O. ;
Gonzalez Sagrado, M. ;
Conde, R. ;
Gonzalez, J. M. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (01) :74-78
[7]   Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients [J].
de Luis, D. A. ;
Aller, R. ;
Izaola, O. ;
Gonzalez Sagrado, M. ;
Conde, R. .
NUTRICION HOSPITALARIA, 2010, 25 (05) :730-735
[8]   EFFECT ON HEPATIC MORPHOLOGY OF TREATMENT OF OBESITY BY FASTING, REDUCING DIETS AND SMALL-BOWEL BYPASS [J].
DRENICK, EJ ;
SIMMONS, F ;
MURPHY, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1970, 282 (15) :829-&
[9]   Protective effect of alcohol consumption for fatty liver but not metabolic syndrome [J].
Hamaguchi, Masahide ;
Kojima, Takao ;
Ohbora, Akihiro ;
Takeda, Noriyuki ;
Fukui, Michiaki ;
Kato, Takahiro .
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (02) :156-167
[10]   A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients [J].
Harrison, SA ;
Fincke, C ;
Helinski, D ;
Torgerson, S ;
Hayashi, P .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (06) :623-628